Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data
Cardiology Department, University Hospital of Strasbourg, Hôpital de Hautepierre Strasbourg, France
revised 30 November 1994; accepted 21 December 1994.
Correspondence: G. Roul, Cardiology Department, University Hospital of Strasbourg, Hôpital de Hautepierre, Avenue Molieère, 67098 Strasbourg Cedex, France.
Abstract
Various parameters have been found useful for establishing the prognosis of patients with chronic heart failure, in particular haemodynamic parameters measured at rest. However, few studies deal with the prognostic value of invasive exercise haemodynamic parameters in such patients. Our aim was to test the value of such parameters to assess the prognosis of patients with chronic heart failure in functional class II or III of the New York Heart Association.
Methods: Between December 1990 and June 1993, 50 patients fulfilled the criteria for inclusion in the study. The average age and ejection fraction of the population were 54 ± 2 years and 20 ± 0.5% respectively. All patients were examined clinically; their invasive haemodynamic parameters were measured at rest and during exercise, and their exercise peak VO2, validated by reaching the anaerobic threshold, was determined. They were followed up for 21.2 ± 1.17 months (ranges 3–26 months). The assessment criteria employed were mortality and the occurrence of major events (heart failure, pulmonary oedema or severe ventricular arrhythmia).
Results: The population consisted of 32 men and 18 women. No gender-related differences were found. Two groups could be distinguished in terms of prognosis: G1: n=
31 living patients with no events, and G2: n=19 deceased or with major events. G1 and G2 were comparable with regard to age, sex ratio and ejection fraction. Several of the 52 parameters tested were different in the two groups, in particular peak VO2, exercise duration, the workload developed during the car diopulmonary test and all the invasive exercise haemodynamic parameters except heart rate (P<0.0001). Haemodynamic parameters at rest had no prognostic value in this series. The ROC curves, the survival curves and the Cox analysis showed that exercise cardiac power output, exercise left ventricular work indices and exercise peak VO2 were the most useful factors for assessing the prognosis of patients with NYHA II or III chronic heart failure. An exercise cardiac power output <2 watts accurately identified those patients with a short-term poor prognosis, and exercise peak VO2 was almost as accurate. To a lesser extent, the NYHA functional class was also an independent prognostic parameter during multivariate analysis.
In conclusion, it appears that invasive haemodynamic parameters are best for determining the prognosis of patients with chronic heart failure. Peak VO2 can, however, be as useful Moreover this is an easily obtainable non-invasive parameter, which makes it more useful in the evaluation and the follow up of such patients.
Key Words: Chronic heart failure • NYHA functional class II or III • rest and exercise right side catheterism • cardio-pulmonary test • prognosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A M A Shehab, R J MacFadyen, M McLaren, R Tavendale, J J F Belch, and A D Struthers Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study Heart, November 1, 2004; 90(11): 1263 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Corra, A. Mezzani, E. Bosimini, and P. Giannuzzi Cardiopulmonary Exercise Testing and Prognosis in Chronic Heart Failure*: A Prognosticating Algorithm for the Individual Patient Chest, September 1, 2004; 126(3): 942 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Meluzin, L Spinarova, L Dusek, J Toman, P Hude, and J Krejci Prognostic Importance of the Right Ventricular Function Assessed by Doppler Tissue Imaging Eur J Echocardiogr, December 1, 2003; 4(4): 262 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nanas, J. Nanas, O. Papazachou, C. Kassiotis, A. Papamichalopoulos, J. Milic-Emili, and C. Roussos Resting Lung Function and Hemodynamic Parameters as Predictors of Exercise Capacity in Patients With Chronic Heart Failure Chest, May 1, 2003; 123(5): 1386 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Scharf, T. Merz, W. Kiowski, E. Oechslin, C. Schalcher, and H. P. Brunner-La Rocca Noninvasive Assessment of Cardiac Pumping Capacity During Exercise Predicts Prognosis in Patients With Congestive Heart Failure Chest, October 1, 2002; 122(4): 1333 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.A. Cooke, S.G. Williams, P. Marshall, J.K. Al-Timman, J. Shelbourne, D.J. Wright, and L.-B. Tan A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients Eur. Heart J., September 1, 2002; 23(17): 1360 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.P. Nicholls, C. O'Dochartaigh, and M.S. Riley Circulatory power--a new perspective on an old friend Eur. Heart J., August 2, 2002; 23(16): 1242 - 1245. [PDF]
|
|
|
|
|
|
A. Cohen-Solal, J.Y. Tabet, D. Logeart, P. Bourgoin, M. Tokmakova, and M. Dahan A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure Eur. Heart J., May 2, 2002; 23(10): 806 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.G Williams, G.A Cooke, D.J Wright, W.J Parsons, R.L Riley, P Marshall, and L-B Tan Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure Eur. Heart J., August 2, 2001; 22(16): 1496 - 1503. [Abstract] [PDF]
|
|
|
|
|
|
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, P. Ponikowski, and A.J.S. Coats Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure Eur. Heart J., January 2, 2000; 21(2): 146 - 153. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Metra, P. Faggiano, A. D'Aloia, S. Nodari, A. Gualeni, D. Raccagni, and L. Dei Cas Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure J. Am. Coll. Cardiol., March 15, 1999; 33(4): 943 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hulsmann, B. Stanek, B. Frey, B. Sturm, D. Putz, T. Kos, R. Berger, W. Woloszczuk, G. Maurer, and R. Pacher Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1695 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Chomsky, C. C. Lang, G. H. Rayos, Y. Shyr, T.-K. Yeoh, R. N. Pierson III, S. F. Davis, and J. R. Wilson Hemodynamic Exercise Testing: A Valuable Tool in the Selection of Cardiac Transplantation Candidates Circulation, December 15, 1996; 94(12): 3176 - 3183. [Abstract] [Full Text]
|
|